PDF(Pubmed)
Abstract：
UNASSIGNED: 3D-printing is a rapidly developing technology with applications in orthopaedics including pre-operative planning, intraoperative guides, design of patient specific instruments and prosthetics, and education. Existing literature demonstrates that in the surgical treatment of a wide range of orthopaedic pathology, using 3D printing shows favourable outcomes. Despite this evidence 3D printing is not routinely used in orthopaedic practice. We aim to evaluate the advantages of 3D printing in orthopaedic surgery to demonstrate its widespread applications throughout the field.
UNASSIGNED: We performed a comprehensive systematic review and meta-analysis. AMED, EMBASE, EMCARE, HMIC, PsycINFO, PubMed, BNI, CINAHL and Medline databases were searched using Healthcare Databases Advanced Search (HDAS) platform. The search was conducted to include papers published before 8th November 2020. Clinical trials, journal articles, Randomised Control Trials and Case Series were included across any area of orthopaedic surgery. The primary outcomes measured were operation time, blood loss, fluoroscopy time, bone fusion time and length of hospital stay.
UNASSIGNED: A total of 65 studies met the inclusion criteria and were reviewed, and 15 were suitable for the meta-analysis, producing a data set of 609 patients. The use of 3D printing in any of its recognised applications across orthopaedic surgery showed an overall reduction in operative time (SMD = -1.30; 95%CI: -1.73, -0.87), reduction in intraoperative blood loss (SMD = -1.58; 95%CI: -2.16, -1.00) and reduction in intraoperative fluoroscopy time (SMD = -1.86; 95%CI: -2.60, -1.12). There was no significant difference in length of hospital stay or in bone fusion time post-operatively.
UNASSIGNED: The use of 3D printing in orthopaedics leads to an improvement in primary outcome measures showing reduced operative time, intraoperative blood loss and number of times fluoroscopy is used. With its wide-reaching applications and as the technology improves, 3D printing could become a valuable addition to an orthopaedic surgeon\'s toolbox.
UNASSIGNED: We performed a comprehensive systematic review and meta-analysis. AMED, EMBASE, EMCARE, HMIC, PsycINFO, PubMed, BNI, CINAHL and Medline databases were searched using Healthcare Databases Advanced Search (HDAS) platform. The search was conducted to include papers published before 8th November 2020. Clinical trials, journal articles, Randomised Control Trials and Case Series were included across any area of orthopaedic surgery. The primary outcomes measured were operation time, blood loss, fluoroscopy time, bone fusion time and length of hospital stay.
UNASSIGNED: A total of 65 studies met the inclusion criteria and were reviewed, and 15 were suitable for the meta-analysis, producing a data set of 609 patients. The use of 3D printing in any of its recognised applications across orthopaedic surgery showed an overall reduction in operative time (SMD = -1.30; 95%CI: -1.73, -0.87), reduction in intraoperative blood loss (SMD = -1.58; 95%CI: -2.16, -1.00) and reduction in intraoperative fluoroscopy time (SMD = -1.86; 95%CI: -2.60, -1.12). There was no significant difference in length of hospital stay or in bone fusion time post-operatively.
UNASSIGNED: The use of 3D printing in orthopaedics leads to an improvement in primary outcome measures showing reduced operative time, intraoperative blood loss and number of times fluoroscopy is used. With its wide-reaching applications and as the technology improves, 3D printing could become a valuable addition to an orthopaedic surgeon\'s toolbox.
摘要：
■3D打印是一种快速发展的技术，在骨科中的应用包括术前计划，术中指南,患者专用器械和假肢的设计，和教育。现有文献表明，在广泛的骨科病理学的手术治疗中，使用3D打印显示出良好的结果。尽管如此，3D打印在骨科实践中并不常用。我们旨在评估3D打印在骨科手术中的优势，以证明其在整个领域的广泛应用。
■我们进行了全面的系统评价和荟萃分析。AMED,EMBASE,EMCARE,HMIC,PsycINFO,PubMed,BNI,使用医疗保健数据库高级搜索（HDAS）平台搜索CINAHL和Medline数据库。搜索包括2020年11月8日之前发表的论文。临床试验,期刊文章,随机对照试验和病例系列包括在骨科手术的任何领域。测量的主要结果是手术时间，失血,透视时间,骨融合时间和住院时间。
■共有65项研究符合纳入标准，并进行了综述，15个适合进行荟萃分析，产生609名患者的数据集。在骨科手术中任何公认的应用中使用3D打印显示手术时间总体减少（SMD=-1.30;95CI：-1.73，-0.87）。术中出血量减少(SMD=-1.58;95CI:-2.16,-1.00),术中透视时间减少(SMD=-1.86;95CI:-2.60,-1.12).术后住院时间和骨融合时间没有显着差异。
在骨科中使用3D打印可以改善主要结果指标，减少手术时间。术中失血量和透视检查的次数。随着其广泛的应用和技术的进步，3D打印可能成为整形外科医生工具箱的一个有价值的补充。
■我们进行了全面的系统评价和荟萃分析。AMED,EMBASE,EMCARE,HMIC,PsycINFO,PubMed,BNI,使用医疗保健数据库高级搜索（HDAS）平台搜索CINAHL和Medline数据库。搜索包括2020年11月8日之前发表的论文。临床试验,期刊文章,随机对照试验和病例系列包括在骨科手术的任何领域。测量的主要结果是手术时间，失血,透视时间,骨融合时间和住院时间。
■共有65项研究符合纳入标准，并进行了综述，15个适合进行荟萃分析，产生609名患者的数据集。在骨科手术中任何公认的应用中使用3D打印显示手术时间总体减少（SMD=-1.30;95CI：-1.73，-0.87）。术中出血量减少(SMD=-1.58;95CI:-2.16,-1.00),术中透视时间减少(SMD=-1.86;95CI:-2.60,-1.12).术后住院时间和骨融合时间没有显着差异。
在骨科中使用3D打印可以改善主要结果指标，减少手术时间。术中失血量和透视检查的次数。随着其广泛的应用和技术的进步，3D打印可能成为整形外科医生工具箱的一个有价值的补充。
